Gautier Bréville

ORCID: 0000-0003-0890-1981

Also affiliated with University Hospital of Geneva, Translational Therapeutics (United States), Geneva College, University of Pennsylvania

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients”.

Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients

medRxiv(2021)10.1101/2021.12.20.21268128

N/A

0DataRank · unranked

25 citations

Nelli Heikkilä, Irène Sabater Royo, Paola Fontannaz, Gautier Bréville, Kim Lauper +9 more

Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccines

medRxiv(2021)10.1101/2021.07.21.21260928

N/A

0DataRank · unranked

16 citations

Kim Lauper, Gautier Bréville, Irène Sabater Royo, Rachel Goldstein, Diego O. Andrey +8 more